The variety of regulatory steps in AML blasts modulating the transferrin receptor reduces the part played by the IRP activity, in agreement with the recently reported evidence of dissociation between TFRC and transferrin receptor concentrations, even with explicit consideration of IRP activity, in cell lines [40]. The gene discussed is WNT2; the disease is acute myeloid leukemia.